Teva Pharmaceutical Industries Ltd. is among the top 15 pharmaceutical companies in the world and is the leader in generic pharmaceuticals, specializing in the development, production and marketing of a wide range of generic, innovative and branded pharmaceuticals, biopharmaceuticals and active pharmaceutical ingredients. Teva currently operates in about 60 countries and has approximately 40,000 employees worldwide. Its innovative R&D efforts focus on therapies for the central nervous system (with emphasis on multiple sclerosis), autoimmune diseases and oncology. Teva differentiates itself through a balanced portfolio, with generic, innovative and branded products; vertical integration of its pharmaceutical and API activities; a combination of large scale operations with local customer responsiveness, and a global footprint. Teva's success lies in the quality of its offerings and its focus on customers and patients.